أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
rabeprazol medical valley magasýruþolin tafla 20 mg
medical valley invest ab - rabeprazolum natríum - magasýruþolin tafla - 20 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
pariet magasýruþolin tafla 10 mg
eisai ab - rabeprazolum natríum - magasýruþolin tafla - 10 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
pariet magasýruþolin tafla 20 mg
eisai ab - rabeprazolum natríum - magasýruþolin tafla - 20 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
rabeprazol medical valley magasýruþolin tafla 10 mg
medical valley invest ab - rabeprazolum natríum - magasýruþolin tafla - 10 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
rabeprazol actavis magasýruþolin tafla 10 mg
actavis group ptc ehf. - rabeprazolum natríum - magasýruþolin tafla - 10 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
rabeprazol actavis magasýruþolin tafla 20 mg
actavis group ptc ehf. - rabeprazolum natríum - magasýruþolin tafla - 20 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
rabeprazol krka magasýruþolin tafla 10 mg
krka sverige ab - rabeprazolum natríum - magasýruþolin tafla - 10 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
rabeprazol krka magasýruþolin tafla 20 mg
krka sverige ab - rabeprazolum natríum - magasýruþolin tafla - 20 mg
الاتحاد الأوروبي -
الأيسلاندية -
EMA (European Medicines Agency)
edurant
janssen-cilag international n.v. - rilpivirin hýdróklóríð - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - edurant, ásamt öðrum antiretroviral lyf, er ætlað fyrir meðferð hiv veira tegund 1 (hiv‑1) sýkingu í andretróveirumeðferð‑barnalegt sjúklingar 12 ára og eldri með veiru hlaða ≤ 100,000 hiv‑1 rna afrit/ml. eins og með aðrar antiretroviral lyf, arfgerðar mótstöðu prófa ætti að fylgja því að nota edurant.
الاتحاد الأوروبي -
الأيسلاندية -
EMA (European Medicines Agency)
epclusa
gilead sciences ireland uc - sofosbuvir, velpatasvir - lifrarbólga c, langvinn - veirueyðandi lyf til almennrar notkunar - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4. 2, 4. 4 og 5.